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Abstract We have examined the role of gicerin, an immuno-
globulin superfamily cell adhesion molecule, in chick sciatic
nerves during development and regeneration. Gicerin was ex-
pressed in the spinal cord, dorsal root ganglion (DRG) and
sciatic nerves in embryos, but declined after hatching. Neurite
extensions from explant cultures of the DRG were promoted on
gicerin’s ligands, which were inhibited by an anti-gicerin anti-
body. Furthermore, gicerin expression was upregulated in the
regenerating sciatic nerves, DRG and dorsal horn of the spinal
cord after injury to the sciatic nerve. These results indicate that
gicerin might participate in the development and regeneration of
sciatic nerves.
' 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Adhesion among cells is an essential property for multicel-
lular organisms in order to organize tissues and organs as well
as to establish and maintain cell^cell interactions [1,2]. Cell
adhesion molecules (CAMs) are recognized as playing a major
role in a variety of physiological and pathological phenomena
such as tissue development, regeneration and tumor progres-
sion [3]. In the nervous system, several CAMs are necessary
for the interaction among neurons, glial cells and target or-
gans, and play important roles such as in neuronal migration
and neurite outgrowth, fasciculation and path¢nding. We
have identi¢ed an integral membrane glycoprotein, gicerin,
from chicken gizzard smooth muscle as a ligand for the neu-
rite outgrowth factor (NOF), which is a laminin-like embry-
onic chick muscle protein [4^6]. Gicerin, the same molecule as
HEMCAM is a homologous molecule to human MUC18/
CD146/Mel-CAM [7^9]. Gicerin exhibits homophilic cell ad-
hesion activity in addition to heterotypic adhesion with re-
spect to NOF [4,5,10]. In the central nervous system of the
chicken, gicerin is expressed during the developmental stage
when neurons migrate or extend neurites to form a neural
network [4,11^13]. Also, gicerin appears transiently in non-
neural tissues of the chick embryo and plays an important
role in development by its cell adhesion activities [11,14,15].
Furthermore, gicerin re-appears on regenerating epithelial
cells of the trachea, oviduct and kidney after injury as well
as tumors [14^20]. Although the expression pattern of gicerin
in the inner ear development and hair cell regeneration has
been reported, the potential role of gicerin in peripheral ner-
vous systems remains unclear [21]. It has been reported that
the developmental expression pattern of certain CAMs is re-
capitulated after peripheral nerve injury, and that this pro-
motes the interaction between axon and axon or axon and
Schwann cells in the regenerating nerves [22,23]. Character-
ization of the development and regeneration of sciatic nerve
provides a good model for understanding the function of mo-
lecular factors in the formation of peripheral nervous systems
[22]. In the present study, we have investigated the expression
and the potential function of gicerin in the development and
regeneration of the sciatic nerve and dorsal root ganglion
(DRG) of the chicken.
2. Materials and methods
2.1. Tissue samples
Embryonic day-8 (E8), newly-hatched and 3-week-old White Leg-
horn chicks were used in the study. Whole embryos and the sacral
spinal cord with DRG and sciatic nerve of the chicks were ¢xed in
Zamboni’s solution for immunohistochemistry. They were also frozen
for Western blot analysis.
2.2. Sciatic nerve injury model
One-week-old chicks were anesthetized by pentobarbital and their
left sciatic nerves were injured (crushed) with a clamp to the femoral
region [24]. Their right-side nerves were not injured and used as a
non-injured control. On the 14 days post injury, the chicks were killed
under deep anesthesia with pentobarbital and their sciatic nerves,
DRGs and sacral spinal cords were removed for immunohistochem-
istry and Western blot analysis.
2.3. Immunohistochemistry
Tissue samples ¢xed in Zamboni’s solution were frozen and cut into
10-Wm sections. DRG explants cultured on a dish (see below) were
also ¢xed in Zamboni’s solution. They were incubated with polyclonal
antibodies for gicerin or for NOF for 1 h at 37‡C [17]. The sections of
the injured and non-injured sciatic nerves were double stained with a
polyclonal antibody for gicerin and a monoclonal antibody for S-100
protein (Sigma). They were visualized with an £uorescein isothiocya-
nate (FITC)-conjugated anti-rabbit IgG and a rhodamine-conjugated
anti-mouse IgG.
2.4. Western blot analysis
Tissue samples were homogenized and solubilized by 10 mM Tris/
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acetate (pH 8.0), 1 mM ethylenediamine tetraacetic acid (EDTA),
0.5% NP-40 and then centrifuged at 40 000Ug for 30 min. The resul-
tant supernatants were separated by sodium dodecyl sulfate^polyac-
rylamide gel electrophoresis (SDS^PAGE), transferred to a polyvinyl-
idene di£uoride (PVDF) membrane and visualized by an enhanced
chemiluminescence (ECL) system using a polyclonal anti-gicerin anti-
body and a secondary anti-rabbit IgG-horseradish peroxidase (HRP)
conjugate [17].
2.5. Assay for neurite extension from DRG
Dishes (3 cm in diameter) were coated with a chimeric protein of
gicerin extracellular domain with human IgG Fc fraction (gicerin-Fc)
(50 Wg/ml) or NOF protein (20 Wg/ml) and incubated for 2 h at 37‡C
[13,15]. DRGs were picked up from E8 chicks and dissociated with
0.05% trypsin and 0.53 mM EDTA for 20 min at room temperature.
After centrifugation at 800Ug for 10 min and gentle suspension in
Dulbecco’s modi¢ed Eagle’s medium (DMEM), they were incubated
on a dish for 40 min at 37‡C and £oating cells were re-plated on non-
coated dishes, gicerin-Fc- or NOF-coated dishes and incubated for
another 12 h at 37‡C in DMEM containing 10% fetal calf serum
(FCS) with a control IgG or an anti-gicerin antibody (4 mg/ml).
Also, an anti-NOF antibody (4 mg/ml) was added in the explants
on the gicerin-Fc-coated dishes and incubated for 12^24 h at 37‡C.
3. Results
3.1. Expression of gicerin in the spinal cord, DRG and sciatic
nerve of chick embryo
In the embryos, gicerin was abundantly observed in the
spinal cord, DRG and other tissues, such as myotomes, chon-
droblasts, blood vessels and notochords. The gray matter of
the spinal cord exhibited signi¢cantly greater staining for gi-
cerin than the white matter (Fig. 1A). The ventral and dorsal
horns and their roots as well as most neurons in the DRG
were gicerin-positive (Fig. 1A^C). The dorsal horn and funi-
culus, especially the region adjacent to the dorsal root were
more strongly stained for gicerin than the ventral side (Fig.
1C). Also, gicerin was observed in the sciatic nerve ¢bers of
the embryo (Fig. 1D). Expression of gicerin was dramatically
decreased after hatching and only the dorsal horn, dorsal root
(Fig. 1E), DRG (data not shown) and sciatic nerve (Fig. 1F)
were weakly positive for gicerin. On the other hand, NOF was
expressed in the pia mater, neurium, myotome, blood vessels
Fig. 1. Expression of gicerin in spinal cord, DRG and sciatic nerve from E8 and newly-hatched chick. Immuno£uorescent staining for gicerin
(A^F) and NOF (G, H). A: Whole view of spinal cord of E8 (transverse section: dorsal is up and lateral is both sides). B: DRG and ventral
root of E8 (transverse section). C: Dorsal horn and dorsal root of E8 (transverse section). D: Sciatic nerve of E8 (longitudinal section). E: Spi-
nal cord of newly-hatched chick (transverse section). F: Sciatic nerve of newly-hatched chick (longitudinal section). G: Whole view of spinal
cord of E8 (transverse section: dorsal is up and lateral is both sides). H: DRG of E8 (transverse section). VE, vertebra; ca, central canal; my,
myotomes. Bar, 200 Wm.
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and notochords in the embryo (Fig. 1G,H), and the expres-
sion level decreased after hatching.
3.2. Neurite extension from DRG explants on gicerin and
NOF proteins
On gicerin-Fc chimeric protein, many neurites were ex-
tended from DRG explants, which were blocked by the
anti-gicerin antibody but not by the anti-NOF antibody
(Fig. 2A^C). On the other hand, only a few neurites were
extended from the explants when they were cultured on the
non-coated dish (Fig. 2D). Immunocytochemically, NOF was
not found on the neurites on gicerin-Fc protein (Fig. 2H).
These results suggested that NOF was not involved in the
neurite extension on gicerin-Fc chimeric protein. Neurite ex-
tension was also prominent on the NOF-coated dish, which
was blocked by the anti-gicerin antibody (Fig. 2E,F). Both the
DRG and extending neurites grown on NOF-coated dish were
positive for gicerin (Fig. 2G). This suggested the involvement
of gicerin in the extension of neuritis on NOF.
3.3. Expression of gicerin in the spinal cord and sciatic nerve
after injury
After 14 days of injury, the injured site of the sciatic nerve
was swollen and whitish, as described by Galloway et al. [24].
Gicerin was strongly re-expressed in the sciatic nerve ¢bers of
the injured side and the distribution of gicerin did not co-
localize with S-100 proteins (Fig. 3B^D), indicating that gicer-
in appeared in axons, not in Schwann cells. And most of the
ganglion cells in the DRG of the injured side strongly re-ex-
pressed gicerin on their surface (Fig. 3F). On the other hand,
gicerin was slightly observed in the sciatic nerve and in the
ganglion cells of the DRG of the uninjured side (Fig. 3A,E).
The S-100 proteins were expressed in the uninjured sciatic
nerves (data not shown). In the spinal cord, expression of
gicerin apparently increased in the dorsal horn of the injured
side (Fig. 3G). NOF expression increased slightly in the neu-
rium of the injured sciatic nerve (data not shown).
The increase of gicerin expression was also con¢rmed by
Western blot analysis. Gicerin was recognized as a doublet
band around 90 kDa and its expression increased only in
the sciatic nerve and DRG of the injured side (Fig. 4).
Fig. 2. Neurite extension from explants of DRG. DRGs from E8
were cultured on gicerin-Fc protein (A), on gicerin-Fc protein with
anti-gicerin antibody (B), on gicerin-Fc protein with anti-NOF anti-
body (C), on non-coated dishes (D), on NOF protein (E) and on
NOF protein with anti-gicerin antibody (F). Neurite extension is ob-
served on both gicerin- and NOF-coated dishes (A, E), but dis-
turbed with anti-gicerin antibody (B, F). Anti-NOF antibody shows
no e¡ect on neurites on gicerin-Fc protein (C). On non-coated dish,
a few neurites emerge from DRG (D). Immunocytochemically, gi-
cerin is expressed on DRG and neurites on NOF protein (G), while
NOF is not found on the neurites on gicerin-Fc protein (H). Bar,
300 Wm.
Fig. 3. Expression of gicerin in sciatic nerve and spinal cord of 3-week-old chicks at 14 days post sciatic nerve injury. Gicerin is not expressed
on nerve ¢bers in normal sciatic nerve of leg which was not operated on (A, gicerin only). In contrast, gicerin was visible in sciatic nerve ¢bers
as bundle-like appearances in injured leg, but did not overlap with distribution of S-100 protein in double staining (B: gicerin; C: S-100 pro-
tein; D: merge). In DRG, gicerin is slightly found on the cell surface of ganglion cells in the side which was not operated on (E), whereas it is
strongly expressed in most ganglion cells in the injury side (F). In spinal cord, the expression level of gicerin is increased in dorsal horn of the
injured side (arrows) compared with the side which was not operated on (arrowheads) (G: dorsal is top and left is injured side). A^D: Longitu-
dinal sections. E^G: Transverse sections. Bar, 100 Wm.
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4. Discussion
In the present study, we ¢rst characterized the expression
pattern of gicerin and its heterophilic ligand, NOF in the
spinal cord, DRG and sciatic nerve during the development.
The sciatic nerve consists of ¢bers from sensory neurons in the
DRG and ¢bers from the motor neurons in the ventral horn,
and both of them were gicerin-positive in the embryonic stage.
On the other hand, NOF was strongly positive in the neurium.
We speculated that gicerin might participate in the formation
of the sciatic nerve by its adhesive activities. Homophilic ad-
hesion of gicerin may promote axonal extension, while its
heterophilic adhesion with NOF may involve in the axonal
guidance on the neurium. To support this paradigm, an in
vitro embryonic DRG culture was performed. We found
that the neurite extension from the DRG explants was
strongly promoted on both gicerin-Fc and NOF proteins,
and these extensions were obviously inhibited by the anti-gi-
cerin antibody. These suggested that gicerin participated in
the neurite extension system. In case of homophilic interac-
tion, we denied the possibility that NOF was secreted from
extending neurons and involved in the neurite extension pro-
cess. Neurons were negative for NOF and anti-NOF antibody
did not inhibit neurite extension on gicerin-Fc. But we cannot
exclude the possibility that there is an unknown heterophilic
ligand on the surface of DRG neurons and it works on the
neurite extension on gicerin-Fc chimeric protein since human
homolog MCAM/CD146/MUC18 is supposed to have a het-
erophilic ligand [25^27]. As for the heterophilic binding activ-
ity to NOF, DRG neurons extended neurites in respond to
NOF and the activity was also blocked by anti-gicerin anti-
body, suggesting the involvement of gicerin^NOF interaction
in the neurite extension.
One particularly interesting and potentially important ¢nd-
ing in the present study was the observation that gicerin re-
appeared on the regenerating axons in the sciatic nerve. This
¢nding suggests a potential function of gicerin in peripheral
nerve regeneration. Gicerin might promote regrowth and fas-
ciculation of regenerating axons by its adhesive activity. Sen-
sory neurons have a potential for central growth when the
peripheral axons regenerate and reorganization occurs both
in the DRG and the spinal cord during the regeneration of
sciatic nerves [22,28]. In the present study, we demonstrated
that gicerin increased in the dorsal horn and DRG after sci-
atic nerve injury. Accordingly, we speculate that gicerin may
be involved in the reorganization of sensory neurons in the
spinal cord during the regeneration of sciatic nerves. The
functional role of gicerin on motor neurons was not eluci-
dated in this study, for which further investigation is needed.
Also, it is strongly expected that elucidating the mechanism
how gicerin participates in the nerve repair might help treat-
ment such as nerve regeneration.
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Fig. 4. Western blot analysis for gicerin protein in DRG and sciatic
nerves from 3-week-old chicks at 14 days post sciatic nerve injury.
Each lane is loaded with 20 Wg of membrane fractions. Lane 1,
DRG from E8. Lane 2, DRG of the injured side from 3-week-old
chick. Lane 3, DRG of the side which was not operated on from
3-week-old chick. Lane 4, sciatic nerve of the injured side from
3-week-old chick. Lane 5, sciatic nerve of the leg which was not
operated on from 3-week-old chick.
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